CVS Health (CVS) Tops Q2 EPS by 36c, Raises FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
CVS Health Reports Strong Second Quarter Results
August 4, 2021 6:30 AM EDTWOONSOCKET, Rhode Island, Aug. 4, 2021 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended June 30, 2021.
Second Quarter Highlights:
Total revenues increased to $72.6 billion, up 11.1% compared to prior year GAAP diluted EPS of $2.10 and Adjusted EPS of $2.42Year-to-date Highlights:
Total revenues increased to $141.7 billion, up 7.3% compared to prior year GAAP diluted EPS of $3.78 and Adjusted EPS of $4.46 Generated cash flow from operations of $8.7 billion Repaid $5.4... More


